GSK’s pain from scandal likely to linger

Guilty verdict may be just the start of its woes

GSK in China: doctor’s orders

Near $500m fine means business practices must change

GSK picks good day to report bribery fine

Bribery settlement with Chinese comes amid flurry of other news

GSK to pay £297m fine for Chinese bribes

Former head of China unit given suspended sentence and deported

Timeline: GSK’s mounting woes in China

High-profile investigation alleged bribery on ‘massive scale’

Glaxo to pay £297m in China bribery case

Pharma group found guilty of bribing non-governmental personnel

GNC fields interest from buyout groups

Vitamin retailer has met with banks to discuss options

Rite Aid cuts profit forecast

Shares fall 19 per cent after warning

US Drugstores: Bitter pill to swallow

Drug retailing in the US is a race to the bottom

NHS workers back strike action over pay

Up to 300,000 Unison members in line for first action in 32 years

Europe struggles to catch US biotech bulls

The Nasdaq biotech index is on the rise again

NHS head backs workplace health plans

Simon Stevens looks to ease pressure on health service

Volunteer given experimental Ebola vaccine

UK trial fast-tracked in response to outbreak in West Africa

Nice urges review of new drug adoption

Regulator wants broad debate on access to new medicines

Study links artificial sweeteners to obesity

Saccharin and other products upset metabolism

AstraZeneca faces up to bittersweet moment

$500m tie-up recognises neuroscience costs but has greater chance of success

Drugmakers unite to tackle Alzheimer’s

Gilead signs deal with India drugmakers

Tie-up with generic producers aims to give affordable access to hepatitis drug Sovaldi

Tougher UK rules proposed for deal promises

Changes come after failed Pfizer bid for AstraZeneca

US more open to obesity drugs

Novo Nordisk medicine liraglutide given nod by US FDA


More FT Twitter accounts